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BoneIndian hedgehog (Ihh) is indispensable for osteoblast differentiation during embryonic development of the
endochondral skeleton. In the absence of Ihh, cells of the osteoblast lineage fail to activate the expression
of Runx2, a transcription factor integral to osteoblast differentiation. However, it is hitherto unclear whether
the lack of Runx2 expression is solely responsible for the failure of osteoblast formation in Ihh-null embryos.
Here, by creating a mouse allele that expresses Runx2 in a Cre-dependent manner, we show that force-
expression of Runx2 in the skeletogenic cells restores bone formation in the Runx2-null, but not in the
Ihh-null embryo. Thus, the mechanism through which Ihh induces osteoblast differentiation requires other
effectors in addition to Runx2.
© 2011 Elsevier Inc. All rights reserved.Introduction
Most elements of the mammalian skeleton originate from a carti-
lage intermediate through endochondrial ossiﬁcation (Kronenberg,
2003). In this process, the skeletogenic mesenchymal cells condense
to form a cartilage anlage composed of chondrocytes and several
layers of surrounding ﬁbroblastic cells that constitute the perichon-
drium. Following the initial phase of proliferation, chondrocytes lo-
cated at the center of the anlage exit the cell cycle and undergo
hypertrophy (increase in cell size). It is at this time that the bone-
forming osteoblasts differentiate from the perichondrium adjacent
to the hypertrophic chondrocytes. Thus, osteoblast differentiation
during endochondral ossiﬁcation is tightly coupled with chondrocyte
development.
Indian hedgehog (Ihh) is a key signal emanating from the chon-
drocytes to induce osteoblast differentiation. Among the three mam-
malian Hedgehog proteins, Ihh is uniquely expressed by
chondrocytes transitioning to the fully hypertrophic state, commonly
known as the prehypertrophic and early hypertrophic chondrocytes
(Lanske et al., 1996; St-Jacques et al., 1999; Vortkamp et al., 1996).niversity School of Medicine,
ll Biology, Indiana University
an Genetics, Baylor College of
rights reserved.Genetic deletion of Ihh in the mouse resulted in a complete lack of os-
teoblasts in the endochondral skeleton (St-Jacques et al., 1999). Sim-
ilarly, ectopic induction of osteoblast differentiation by precocious
hypertrophic chondrocytes in a chimeric mouse model also required
Ihh (Chung et al., 2001). Moreover, studies of Smoothened (Smo),
which encodes a 7-pass transmembrane protein indispensable for
Hh signaling in the receiving cell, demonstrated a cell-autonomous
requirement for Smo in the perichondrium for osteoblast differentia-
tion (Long et al., 2004). These studies support a direct role for Ihh sig-
naling in osteoblastogenesis.
The mechanism through which Ihh induces osteoblast differentia-
tion is not well understood. Analyses of the Ihh−/− embryo have
revealed that the perichondrium is severely hypoplastic, and that none
of the knownmarkers for the osteoblast lineage is detectable, indicating
that the differentiation process is arrested at a very early stage (Hu et al.,
2005; St-Jacques et al., 1999). Although our previous work has shown
that Ihh exerts its osteogenic effect through both Gli3 suppression and
Gli2 activation (Hilton et al., 2005; Joeng and Long, 2009), the relevant
target genes for either Gli2 or Gli3 are not known.
Runx2, a runt-domain transcription factor, is an attractive candi-
date as an important mediator for the osteogenic activity of Ihh. Mo-
lecular and genetic studies have established the essential role of
Runx2 in osteoblast differentiation (Ducy et al., 1997; Lee et al.,
1997; Mundlos et al., 1997; Otto et al., 1997). Importantly, similar to
Ihh removal, deletion of Runx2 in the mouse leads to no osteoblasts,
and hypoplasia of the perichondrium (Komori et al., 1997; Otto et
al., 1997). Moreover, Runx2 expression in the perichondrium was
abolished in the Ihh−/− embryo. These ﬁndings raise the possibility
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to restore osteoblast differentiation in Ihh−/− embryos. Here we test
this possibility by genetic means.
Results
Generation of amouse strain expressing Runx2 in a Cre-dependent manner
To create a versatile tool to express Runx2 in a tissue-speciﬁc man-
ner, we modiﬁed the Rosa26 genomic locus through homologous
recombination so that Runx2 expression can be achieved following
Cre-mediated recombination (Fig. 1A). The modiﬁed allele was
termed R26Runx2. As expected, mice carrying either one or two copies
of the allele (genotypes designated R26Runx2/+ or R26Runx2/Runx2,
respectively) were completely normal.When thesemicewere crossed
with a Col2-Cre transgenic line that targets both chondrocyte and os-
teoblast lineages in the endochondral skeleton, they produced proge-
nies with the genotype of Col2-Cre; R26Runx2/+ (or C2Cre; R26Runx2/+)
that were viable and possessed a relatively normal skeleton at E18.5
(Fig. 1B1–B2).
Forced expression of Runx2 rescues bone formation in Runx2-null mice
To determine the efﬁcacy of Runx2 expressed from the R26Runx2 al-
lele, we testedwhether activation of the allele in the skeletogenic cells
could functionally replace the endogenous Runx2 alleles in the embry-
onic skeleton. Speciﬁcally, we generated Runx2-null embryos
(Runx2−/−), and those that also carried the Col2-Cre transgene, and
one or two R26Runx2 alleles (Runx2−/−; C2Cre; R26Runx2/+, or
Runx2−/−; C2Cre; R26Runx2/Runx2, respectively). When analyzed at
E18.5 by whole-mount skeletal staining, the Runx2−/− embryos,
exhibited no alizarin red staining throughout the body except for the
zeugopod (Fig. 1B3). This staining pattern was consistent with the
previous reports that the Runx2−/− embryos possessed no bone and
only a small amount of mineralized cartilage in the zeugopod.Fig. 1. (A) Diagram for generation of the R26Runx2 allele. (B) Whole-mount skeleImportantly, the Runx2−/− embryos expressing one or two R26Runx2
alleles exhibited progressively more alizarin red staining character-
istic of bone (distinguishable from mineralized cartilage by a
more intense red color) (Fig. 1B4–B5). The restoration of bone for-
mation in the endochondral skeleton but not the skull was consis-
tent with the speciﬁc targeting of Col2-Cre to the former. Thus,
activation of the R26Runx2 allele in the endochondral skeleton is suf-
ﬁcient to restore bone formation in the Runx2-null embryo.
To corroborate the ﬁndings above, we conducted further analyses
of the tibia. H&E staining of longitudinal sections from E18.5 embryos
conﬁrmed that activation of the R26Runx2 allele in the wild-type back-
ground (C2Cre; R26Runx2/+) did not overtly alter the morphology of
the cartilage, the bone collar or the marrow (Fig. 2A–B). On the
other hand, the Runx2−/− tibia lacked a bone collar or a marrow cav-
ity, but possessed an elongated region of hypertrophic chondrocytes
(Fig. 2C). In contrast, the Runx2−/− embryos expressing one or two
R26Runx2 alleles formed a bone collar (Fig. 2D–E). Surprisingly, a mar-
row cavity was only observed in the embryos expressing two R26Runx2
alleles, revealing a dependence of marrow formation on Runx2 dosage
(see Discussion). Moreover, no trabecular bone was observed within
the marrow cavity of the Runx2−/− embryos expressing two
R26Runx2 alleles. Nonetheless, these results conﬁrm that activation of
a single R26Runx2 allele is sufﬁcient to induce osteoblast differentiation
within the perichondrium in the absence of endogenous Runx2.
The efﬁcacy of the R26Runx2 allele was further demonstrated by
molecular analyses of the tibia in E18.5 embryos. In situ hybridization
conﬁrmed that Runx2 was normally expressed in the perichondrium
and the primary spongiosa, and at a lower level in the prehyper-
trophic and early hypertrophic cartilage (Fig. 3A1). Notably, promi-
nent Runx2 signals were also detected in the perichondrium and
the cartilage of the Runx2−/− embryo (which did not possess a pri-
mary spongiosa) (Fig. 3A2), indicating that the Runx2-null allele pro-
duced a mutant mRNA sufﬁciently stable to be detected by the in situ
probe (see Methods). Moreover, activation of either one or two
R26Runx2 alleles did not noticeably increase the overall Runx2 signal,tal staining of E18.5 mouse embryos. Arrows denote mineralized cartilage.
Fig. 2. H&E staining of the tibia from E18.5 embryos. Proximal ends to the left. Boxed regions shown at a higher magniﬁcation below. Scale bar: 100 μm. Asterisks denote bone collar.
H: hypertrophic zone.
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(Fig. 3A3–A4). Further analyses of other osteoblast-lineage markers
revealed that the Runx2−/− tibia expressed alkaline phosphatase
(AP) and bone sialoprotein (Bsp) in the perichondrium, but no osterix
(Osx) or osteocalcin (OC) (Fig. 3B2–E2). On the other hand, activation
of either one or two R26Runx2 alleles induced the expression of both
Osx and OC in the Runx2−/− embryos (Fig. 3D3–E3, D4–E4). Thus,
molecular analyses further corroborated that activation of the
R26Runx2 allele restored the entire osteogenic program in the peri-
chondrial cells in the absence of endogenous Runx2.Fig. 3. In situ hybridization of osteoblast markers. Shown are longitudinal sections through
perichondrium; PEH: prehypertrophic and early hypertrophic region; PS: primary spongiosForced expression of Runx2 promotes chondrocyte hypertrophy in
Runx2-null mice
Activation of the R26Runx2 allele also accelerated chondrocyte hy-
pertrophy in the Runx2−/− embryo. Apart from the lack of mature os-
teoblasts, Runx2 deletion was known to cause a marked delay in
cartilage hypertrophy and the subsequent mineralization throughout
the endochondral skeleton. This deﬁciency was already evident from
the lack of alizarin red staining in most of the skeleton at E18.5
(Fig. 1B3), and was conﬁrmed here by analyses of the femur. Indeed,the tibia of E18.5 embryos, with proximal ends to the left. Signals shown in red. PC:
a.
Fig. 4. Analyses of humeri at E18.5. Proximal ends to the left. (A1–D1) H&E staining. (A2–D2) In situ hybridization of Col10a1. Red lines denote hypertrophic zone. BM: bonemarrow.
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region had been replaced by a marrow cavity (Fig. 4A1–A2), the
Runx2−/− sample showed little sign of cellular hypertrophy (identiﬁ-
able by a lighter H&E staining) (Fig. 4B1), and only minimal expression
of Col10a1, a molecular marker for early and mid-stage hypertrophic
chondrocytes (Fig. 4B2). Importantly, activation of one or two
R26Runx2 alleles in the Runx2-null background induced chondrocyte hy-
pertrophy, although only two alleles led to the formation of a nascent
marrow cavity (Fig. 4C1–C2, D1–D2). All together, the data so far dem-
onstrate that exogenous Runx2 expression from the R26Runx2 allele is
sufﬁcient to cause both osteoblast differentiation and cartilage hypertro-
phy in the absence of endogenous Runx2.
Runx2 does not restore osteoblast differentiation in Ihh-null embryo
Having established that activation of a single R26Runx2 allele was
sufﬁcient to restore osteoblastogenesis in Runx2−/− embryos, we
next tested whether it could do the same in the Ihh−/− embryo. To
this end, we generated littermate embryos that were either Ihh−/−
only, or Ihh−/− but also carried the Col2-Cre transgene and one
R26Runx2 allele (Ihh−/−; C2Cre; R26Runx2/+). Whole-mount staining
at E18.5 revealed that the skeletons of the two embryos were very
similar, except that the Runx2-expressing embryo displayed more in-
tense alizarin red staining (reﬂecting more cartilage mineralization,
see below) throughout the endochondral skeleton (Fig. 5A2–A3).
Likewise, histological analyses showed that R26Runx2 expression did
not alter the limb skeletal morphology characteristic of the Ihh−/−
embryo (Fig. 5C1–D1). However, a closer examination revealed that
Runx2 expression further reduced the zone of nonhypertrophic chon-
drocytes in the Ihh−/− embryo (Fig. 5C2–D2). Moreover, in situ hy-
bridization demonstrated that Runx2 expression accelerated the
progression of hypertrophic chondrocytes from the Col10a1- (early
and mid-stage hypertrophy) (Fig. 6B1–C1) to the Mmp13-
expressing (late hypertrophy) stage in Ihh–/– embryos (Fig. 6B2–C2);
this acceleration is expected to increase mineralization that could ac-
count for themore intense alizarin red staining described above. Thus,
force-expression of Runx2 further expedited chondrocyte hypertro-
phy in the absence of Ihh.
However, Runx2 expression did not lead to bone formation in the
Ihh−/− embryo. Indeed, the perichondrium fromwhich the bone collar
normally forms stayed thin regardless of Runx2 expression (arrows,
Fig. 5C2–D2). Molecular analyses conﬁrmed that AP, Bsp, Osx and Oc
were not induced in the perichondrium in Ihh–/– embryos by Runx2 ex-
pression (Fig. 6A3–C6). Thus, force-expression of Runx2 failed to rescue
osteoblast differentiation in the absence of Ihh.Discussion
We have genetically tested the hypothesis that Runx2 alone medi-
ates the function of Ihh in osteoblast differentiation. By force-
expressing Runx2 in the skeletogenic cells, we show that Runx2 is
sufﬁcient to rescue osteoblastogenesis in the Runx2−/− but not the
Ihh−/− embryo. Thus, induction of osteoblast differentiation by Ihh
most likely requires other effectors besides Runx2.
We cannot exclude the possibility that a higher level of Runx2 ex-
pression might restore osteoblast differentiation in the absence of
Ihh. Indeed, the level of Runx2 from the R26Runx2 allele was likely to
be low as in situ hybridization (with a probe detecting transcripts
from the Runx2-wild type, the Runx2-null and the R26Runx2 allele)
did not detect an obvious increase in overall Runx2 mRNA when the
R26Runx2 allele was activated (Fig. 3A3–A4). Moreover, a dose-
dependent effect was observed in the experiments with Runx2−/−
embryos (Fig. 1B4–B5). We have attempted to generate Ihh−/− em-
bryos expressing two R26Runx2 alleles without success, due to unex-
plained early embryonic lethality. Nonetheless, because a single
R26Runx2 allele was sufﬁcient to restore osteoblast differentiation in
the absence of endogenous Runx2, we conclude that the defect
caused by Ihh removal was greater than the loss of Runx2.
Notably, restoration of bone formation in the Runx2−/− embryo
was restricted to the diaphyseal region where a bone collar would
normally form. This was so even though the Col2-Cre transgene that
was used to activate Runx2 expression targeted all chondrocytes
and perichondrial cells (Long et al., 2001b). Similarly, overexpression
of Runx2 in the wild type background did not cause any ectopic oste-
oblast differentiation. Thus, Runx2 alone appeared to be insufﬁcient
to induce osteoblast differentiation from all perichondrial cells. This
conclusion is in agreement with a previous report that viral expres-
sion of Runx2 in the chick limb bud did not induce ectopic osteoblast
differentiation (Stricker et al., 2002). Furthermore, targeted overex-
pression of Runx2 in osteoblasts was previously shown to inhibit
their maturation and to cause osteopenia in postnatal mice (Liu et
al., 2001). It will be of interest to determine in the future whether
overexpression of Runx2 from the R26Runx2 allele has a similar post-
natal bone phenotype.
We have conﬁrmed the positive role of Runx2 in chondrocyte hy-
pertrophy. This was most evident in the experiments with the
Runx2−/− embryos, wherein force-expression of Runx2 restored
chondrocyte hypertrophy that was otherwise absent in most of the
endochondral cartilage elements at E18.5. Similarly, Runx2 force-
expression further expedited the hypertrophic program in the
Ihh−/− embryo. These results are consistent with the previous
Fig. 5.Morphological analyses of Ihh−/− embryos expressing Runx2. (A) Whole-mount skeletal staining. (B) H&E staining of longitudinal sections of the tibia. Proximal ends to the
left. Boxed areas in B1–D1 shown at a higher magniﬁcation in B2–D2 and B3–D3. Scale bar: 100 μm. t: tibia; f: ﬁbula; NH: nonhypertrophic chondrocytes; H: hypertrophic chon-
drocytes. Arrows denote hypoplastic perichondrium. Asterisk denotes bone collar.
80 X. Tu et al. / Developmental Biology 362 (2012) 76–82ﬁnding that direct expression of Runx2 from a Col2a1 promoter re-
stored chondrocyte hypertrophy in the Runx2−/− embryo (Takeda
et al., 2001).
It is worth noting that in either Runx2−/− or Ihh−/− background, ac-
tivation of a single R26Runx2 allele did not restore vascularization of the
hypertrophic cartilage, even though hypertrophy appeared to have
reached an advanced stage as judged by Mmp13 expression
(Fig. 6C2). This could be explained partly by a dose-dependence on
Runx2, as activation of two R26Runx2 alleles led to partial vascularization
of the hypertrophic region in Runx2–/– embryos (Fig. 2E). Because
Runx2was shown to induce Vegfa expression in hypertrophic chondro-
cytes (Zelzer et al., 2001), it is conceivable that a threshold level of Vegfa
could only be achieved by a higher level of Runx2. Alternatively, the re-
sults could mean that spatial and temporal regulation of Runx2 expres-
sion (which is missing from the R26Runx2 allele) is critical for proper
vascularization of the cartilage. Finally, in the case of Ihh−/− embryos,the failure of cartilage vascularization may be due to reasons indepen-
dent of Runx2; this view is consistentwith the relatively normal expres-
sion of Runx2 in the hypertrophic chondrocytes of Ihh−/− embryos (Hu
et al., 2005; St-Jacques et al., 1999). In summary, the present study calls
for future studies to discover the critical mediators of Ihh function in
cartilage vascularization and osteoblast differentiation.
Methods
Mouse strains
The Runx2+/−, Ihh+/− and Col2-Cre (line 3) mouse lines are as
previously described (Long et al., 2001b; Otto et al., 1997; St-Jacques
et al., 1999). The Runx2+/− mouse was generously provided by Dr.
Gerard Karsenty (Columbia University, NY). To generate the
R26Runx2 mouse, the mouse Runx2 cDNA encoding the MASNS
Fig. 6.Molecular analyses of Ihh−/− embryos expressing Runx2. Shown are in situ hybridization results from longitudinal sections through the hindlimb. Signals in red. t: tibia; f: ﬁbula.
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cloned into pCIG (Megason and McMahon, 2002), pBIG-T (Srinivas
et al., 2001) and pRosa-PAS (Soriano, 1999; Srinivas et al., 2001) to
produce the ﬁnal construct pR26-Runx2. Speciﬁcally, a DNA fragment
containing 123 nt of the 5′UTR and the entire coding sequence for
MASNS Runx2 was released from “pBS Cbfa1 sh” by XhoI and XbaI,
and cloned into XhoI and EcoRV sites of pCIG. The resultant plasmid
was then digested with SalI and the relevant piece cloned into the
same site in pBigT. Finally, the Runx2-containing fragment was
cloned into the PacI/AscI sites of pRosa-PAS. The ﬁnal construct was
then linearized and electroporated into RW-4 ES cells (Murine Em-
bryonic Stem Cell Core, Siteman Cancer Center, Washington Universi-
ty School of Medicine). The correctly targeted ES clone was identiﬁed
by Southern analyses with a previously described probe (Kisseberth
et al., 1999). Chimeric mice were generated by injecting ES cells
into C57BL6 blastocytes (Tg/KO Micro-injection Core, WashingtonUniversity School of Medicine). PCR with ear biopsy samples were
performed to determine germline transmission and for subsequent
genotyping (Soriano, 1999). All animal studies were approved by An-
imal Studies Committee at Washington University.
Analyses of mouse embryos
Whole mount skeletal staining was performed with alizarin red
and alcian blue as previously described (Long et al., 2001a). Embryon-
ic limbs were sectioned after ﬁxation in 10% buffered formalin over-
night at room temperature, and embedded in parafﬁn. Limbs from
E18.5 embryos were decalciﬁed in 14% EDTA/PBS (pH7.4) for 48 h
after ﬁxation and before processing. In situ hybridization was per-
formed by using 35S-labeled riboprobes as previously described
(Hilton et al., 2005; Hu et al., 2005; Long et al., 2001b, 2004). The
Runx2 probe includes 221 nt of the 5′UTR and much of the ﬁrst
82 X. Tu et al. / Developmental Biology 362 (2012) 76–82coding exon of the transcript producing the MASNS isoform, and rec-
ognizes not only the wild type mRNA, but also the transcripts from
the null allele (which replaces part of the second coding exon and
the rest of the gene with a LacZ expression cassette) and the
R26Runx2 allele (which includes 123 nt of the 5′UTR and the entire
coding sequence for MASNS).
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